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Poland—time to move on!
Authors’ reply  We appreciate the interest 
generated by our recent stroke thrombectomy 
clinical vignette.1 A clinical vignette, opposite 
to an isolated case report, illustrates the fate of 
not one but hundreds of acute ischemic stroke 
(AIS) patients who continue to join (with all con‑
sequences) the severe disability lists because 
of a failed delivery of mechanical thrombec‑
tomy (MT), which is today not an “additional” 
treatment but the guideline ‑mandated, class 
of recommendation 1A, level of evidence 1 
management.2
Messages highlighted by international key 
opinion leaders from 5 countries / 3 continents 
(including neuroradiology and neurosurgery) 
and by everyday MT operators (including cardi‑
ology) are consistent and unsurprising: 1) time 
is the fundamental principle in AIS—patients 
revascularized in 2 hours or less from stroke 
onset achieve approximately 90% good recovery 
whose likelihood, however, declines very signif‑
icantly with time; thus, any avoidable transpor‑
tation for MT harms severely; 2) with sparse‑
ly located comprehensive stroke centers (CSCs) 
and far too few operators, no neuroradiology‑
‑based system can effectively address the mag‑
nitude of the needs; 3) Poland’s MT deliverabili‑
ty is amongst the world’s lowest; 4) stroke inter‑
national guidelines are clear on what and how 
should be done, and this is paralleled by work‑
ing examples from different healthcare systems.
In Poland, a  country of approximately 
38 million residents, only 1111 MTs occurred 
between January and November 2019 (Na‑
tional Health Fund data; Stroke MT Program),1 
reaching a delivery level of less than 20% to 
25%. With 60 000 strokes, Polish AIS patients 
require a minimum of 6000 to 8000 (and up to 
some 20 000) MTs per year. Thus, today, for ev‑
ery 5 patients with large ‑vessel occlusion AIS, 
less than 1 receives MT. For those supposed‑
ly fortunate to receive MT, many receive it too 
late for a full clinical recovery or a meaningful 
reduction of disability. Poland, once an inter‑
national model of the heart attack care, is now 
amongst the 3 European leaders in the system‑
ic failure of MT delivery for level of evidence 1A 
stroke clinical scenarios.3 According to a large in‑
ternational survey, today it is better to be an av‑
erage AIS patient in India (where the majority 
is not insured) than an average stroke patient 
in Poland.3 If there “are” any true yet “different” 
data, those must be openly provided.
Reasons for failed MT deliveries are more 
than one,1 but Poland’s far ‑too ‑small number of 
MT centers and poor access to MT on a real (rath‑
er than theoretical) 24/7/365 basis is the num‑
ber 1 reason communicated to the world by Po‑
land’s neurology and CSC MT leaders.4
Local multispecialty teams work well, joint in 
their common service to their community, un‑
less5 and until1 disrupted by external politics fo‑
cused on falsely perceived territorial protection 
rather than serving the needs of the patients. In 
AIS, territorial “protection”5 might be regarded 
excusable only if the ones considering themselves 
the “owners” of the territory were able to deliver 
what in the contemporary world is a must ‑do.2 
“Protection” of a territory (“domain”) at the cost 
of increased numbers of invalids (number need‑
ed to treat [NNT], 2.6) and dead bodies (NNT, 31) 
is not acceptable.5 Contrary to the Ministry of 
Health regulations1 endorsed by the Polish neu‑
rology leaders, subsequent stroke management 
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guidelines from the Polish Neurological Soci‑
ety state that “MT should be the domain of spe‑
cialists in radiology, neurology or neurosurgery” 
(whose shortage translates into a greatly unmet 
need)4 and step back (contrary to the Polish reg‑
ulations,1 international guidelines,2 and stroke 
thrombectomy trials’ common practice) to the 
“on‑site neurosurgery requirement” as a practical 
means to block creation of thrombectomy‑capa‑
ble centers. It is regrettable that our local neurol‑
ogy colleagues1 were pressed by the manuscript 
reviewer to remove their names from the pub‑
lication.1 The problem of the patients, similarly 
untreated before and after the one described in 
the vignette1 or systematically treated too late 
to achieve optimal outcomes because of insist‑
ing on avoidable transportation, remains. Lo‑
cal stroke neurologists will hopefully continue 
their work in the multispecialty Task Force1 es‑
tablished to make MT available routinely to their 
patients, in their high ‑volume hospital.
Stroke is not a primary disease of the neuron 
but a vascular problem of the arteries that sup‑
ply the brain. We call upon the stroke manage‑
ment stakeholders in Poland to come to one ta‑
ble (as we did when defining, under the auspic‑
es of the Ministry of Health, common require‑
ments for MT operators),1 and set up—with 
the map of Poland on the wall—an improve‑
ment process to provide a real rather than the‑
oretical access to MT. With the magnitude of 
the misery, time is high today to replace those 
seemingly clever “yes‑(but of course no)s” and 
glimpses in the eyes—with a sparkle for ac‑
tion. It is 100% clear that neither 17 nor 25 
CSCs would ever be able to provide an opera‑
tional (rather than theoretical) stroke MT ser‑
vice to a country of 38 million people. An occa‑
sional helicopter (rather than road) transport 
of a VIP solves neither the stroke problem of 
the VIP (considerable neuronal loss with avoid‑
able transportation from a thrombectomy‑ca‑
pable center to a CSC and logistics, resulting in 
an increased stroke size) nor that of other pa‑
tients who could (and should) be treated on‑
‑site rather than late or not at all.
Ill politics may slow down, but it shall not 
stop, the progress of medicine.5 Cardiac cath‑
eterization laboratory–based thrombectomy‑
‑capable centers, as defined by stroke physi‑
cians2 (termed “level 2” MT centers in neurora‑
diology guidelines), are a fact in the world. In 
many countries, including Poland’s neighbors, 
they deliver MT and the results not different 
from those in leading neuroradiology centers. 
Poland has presently ZERO of those.
How many more—avoidable—stroke vic‑
tims and—avoidable—severe disabilities, in‑
cluding our work colleagues, public figures, or 
the decision ‑makers’ family members, are need‑
ed before the MT system in Poland gets fixed?
